Dermatology Nurses' Association

Dialogues in Immune-Mediated Inflammatory Diseases and Biologic Therapies

Upon completion of this symposium, participants will be better able to:

1. Identify the clinical utility of currently available and emerging biologic therapies in the management of autoimmune diseases.
2. Explain the effectiveness, safety, tolerability, and proper administration of biologic therapies.
3. Integrate patient and practice management strategies to improve the outcomes of patients receiving biologic therapies.

Topical Acne Agents: Strategies for Increasing Compliance and Adherence

Upon completion of this symposium, participants should be better able to:

1. Review current and evolving data regarding the optimal use of topical agents in the management of moderate to severe acne.
2. Identify important issues related to compliance and adherence among patients.
3. Outline how different application strategies affect compliance.
4. Describe an evidence-based approach to developing strategies that may optimize patient outcomes.

Master Clinicians Present™ Act on Acne
Perspectives on P acnes: Resistance and Compatibility in the Use of Topical Combination Agents in the Management of Moderate-to-Severe Acne

At the completion of this podcast, participants should be able to:

1. Discuss current and evolving data regarding the use of topical combination agents in the management of acne
2. Provide perspective on issues related to antibiotic resistance, side effect profiles, and product stability
3. Employ an evidence-based approach to the optimal use of topical combinations for the treatment of acne

Master Clinicians Present™
Hot Topics in the Management of Atopic Dermatitis

At the completion of this activity, participants should be able to:

1. Describe the similarities and differences and discuss the current and emerging evidence regarding the use of currently available steroid-containing topical agents in the management of atopic dermatitis
2. Differentiate clinical severity levels as they relate to atopic dermatitis and identify and select appropriate topical interventions to achieve prompt disease remission and minimize flares
3. Identify evidence-based selection of topical agents based on safety and efficacy profiles, patient characteristics and age, via case-based discussions
4. Establish a continuum of care for the management of atopic dermatitis that optimizes treatment selection and maximizes patient outcomes